No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
367 |
4. Check minimum number of eventsNone |
367 |
5. Include endpointsNone |
367 |
6. Filter based on genotype QC (FinnGen only) |
315 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Kela reimbursement Agammaglobulinemia (D80-84)
based on the number of shared cases.
Similar with more cases:
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any reimbursement code in KELA
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 979 | 566 | 411 |
| Only index persons | 863 | 510 | 353 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 42.67 | 45.86 | 38.29 |
| Only index persons | 41.96 | 46.26 | 35.76 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 315 | 206 | 109 |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | 0.05 |
| Median age at first event (years) | 44.54 | 46.26 | 41.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 328
- Matched controls
- 3280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
307.7
288
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
307.7
328
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
238.8
199
*
ZX120
NOMESCO Finland
Intravenous
27.0
206.5
184
148
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
33.1
179.8
129
63
WW200
NOMESCO Finland
Immunization
46.4
155.7
96
29
J47
ICD-10 Finland
Bronchiectasis
82.1
131.8
71
11
J01MA12
ATC
levofloxacin; systemic
13.5
129.2
180
271
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
49.2
126.8
76
20
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
22.0
124.4
103
67
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
114.4
103
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
114.4
103
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
14.0
112.8
129
145
J01MA14
ATC
moxifloxacin; systemic
14.3
112.7
126
137
TDM10
NOMESCO Finland
Puncture of maxillary antrum
19.3
105.8
92
65
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
23.7
103.6
80
44
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.4
85.6
139
239
6BA02, ,
NOMESCO Finland
528.7
85.2
81
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
82.9
76
*
TPH04
NOMESCO Finland
Cathetrisation of vein
8.2
82.8
183
437
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
12.1
79.9
93
104
J18.9
ICD-10 Finland
Pneumonia, unspecified
8.0
79.7
174
408
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
43.1
78.5
48
13
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
12.7
78.1
87
91
C01CA24
ATC
epinephrine; parenteral
10.3
77.3
104
141
GD1AA
NOMESCO Finland
Thorax X-ray examination
10.0
75.3
266
986
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
72.7
67
*
TGC00
NOMESCO Finland
Bronchial lavation
25.0
69.6
51
24
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
68.1
63
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
12.8
67.8
73
72
R50.9
ICD-10 Finland
Fever, unspecified
7.3
66.8
136
290
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
15.1
65.1
62
50
XW000
NOMESCO Finland
Bone marrow biopsy
18.2
64.6
55
36
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
12.0
63.4
71
74
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
62.5
58
*
H02AB06
ATC
prednisolone; systemic
7.8
61.9
258
1049
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
9.9
61.1
80
103
GD1AD
NOMESCO Finland
Thorax CT examination
11.3
60.0
70
77
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
6.1
59.9
179
539
H02AB09
ATC
hydrocortisone; systemic
18.6
57.5
48
30
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
6.1
56.5
146
383
UDH02
NOMESCO Finland
Rhinopharyngoscopy
8.5
56.1
85
130
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
19.6
53.2
43
25
Z01.8
ICD-10 Finland
Other specified special examinations
5.6
52.8
158
467
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.0
52.4
83
133
J01.0
ICD-10 Finland
Acute maxillary sinusitis
5.3
50.5
189
668
J45.1
ICD-10 Finland
Nonallergic asthma
7.6
47.6
78
129
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.1
45.7
69
104
XG410
NOMESCO Finland
Flow-volume spirometry
12.6
44.3
46
42
R03BB04
ATC
tiotropium bromide; inhalant
7.7
42.4
67
106
J01FA06
ATC
roxithromycin; oral
4.7
41.5
209
893
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.6
41.4
171
631
H02AB07
ATC
prednisone; oral
5.7
41.0
94
215
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
39.4
37
*
OAB50, ,
SPAT
6.8
38.9
69
123
SPAT1262
SPAT
Handing over of treatment supplies
5.2
38.4
102
264
A41.9
ICD-10 Finland
Sepsis, unspecified
13.3
38.3
38
32
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.2
37.7
55
79
J01FA15
ATC
telithromycin; oral
5.8
37.7
82
178
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.1
37.6
77
158
J45.9
ICD-10 Finland
Asthma, unspecified
4.6
37.3
123
378
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
9.0
36.8
49
63
A07AA02
ATC
nystatin; oral
8.2
35.4
51
72
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.5
35.3
120
375
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
9.6
34.3
43
51
J01MA02
ATC
ciprofloxacin; systemic
3.9
33.5
177
752
UJF30
NOMESCO Finland
Ileoscopy through colon
5.4
33.4
78
179
J46
ICD-10 Finland
Status asthmaticus
12.5
33.2
34
30
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.3
32.9
79
186
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.2
32.4
63
122
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.3
31.3
50
79
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
4.6
31.1
259
1471
J01FF01
ATC
clindamycin; systemic
3.8
30.4
145
567
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.9
30.4
51
85
R03DA04
ATC
theophylline; systemic, rectal
10.5
30.3
35
37
WZC30
NOMESCO Finland
Teaching
4.2
29.5
103
324
J01FA10
ATC
azithromycin; systemic
5.0
29.1
276
1681
JN4BD
NOMESCO Finland
Extensive body CT
5.5
29.0
64
139
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
5.7
28.9
60
123
J45.8
ICD-10 Finland
Mixed asthma
10.1
28.8
34
37
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
28.6
27
*
ZXA10
NOMESCO Finland
Bilateral
4.1
28.4
104
337
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
10.4
28.4
33
35
R03DC03
ATC
montelukast; oral
3.9
28.2
112
384
L03AA02
ATC
filgrastim; parenteral
9.4
28.0
35
41
R03BA02
ATC
budesonide; inhalant
3.9
28.0
111
380
R01AD09
ATC
mometasone; nasal
3.7
27.9
227
1230
WW500
NOMESCO Finland
Blood transfusion
8.7
27.8
37
47
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
27.5
26
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
9.4
27.1
34
40
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
8.6
26.0
35
45
R01AD08
ATC
fluticasone; nasal
3.4
26.0
158
707
R03BB01
ATC
ipratropium bromide; inhalant
10.9
26.0
29
29
R03AC02
ATC
salbutamol; inhalant
3.9
25.7
250
1484
R03BA08
ATC
ciclesonide; inhalant
4.9
25.5
65
159
Z3231
NOMESCO Finland
Registered nurse
3.4
25.1
143
613
J01FA09
ATC
clarithromycin; systemic
3.3
24.9
162
750
ZX112
NOMESCO Finland
Subcutaneous
10.2
24.8
29
31
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
24.6
84
257
JN4AD
NOMESCO Finland
Body CT examination
4.7
24.4
64
160
M05BA04
ATC
alendronic acid; oral
6.2
23.9
44
80
UJF32
NOMESCO Finland
Coloscopy
3.5
23.6
112
426
J32.4
ICD-10 Finland
Chronic pansinusitis
24.3
23.5
33
15
A04AA01
ATC
ondansetron; systemic, rectal
5.1
23.5
55
125
B29
ICPC
Lymph/immune mech sympt/complt other
58.6
23.4
27
5
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.0
23.4
82
255
TAB00
NOMESCO Finland
Lumbar puncture
5.9
23.2
45
86
WVA20
NOMESCO Finland
Medicine administration
8.5
22.9
31
40
C03CA01
ATC
furosemide; systemic
3.6
22.3
96
342
R03AK08
ATC
formoterol and beclometasone; inhalant
5.9
22.2
43
82
R05
ICD-10 Finland
Cough
3.3
21.9
113
450
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
33.8
21.9
28
9
WZC00
NOMESCO Finland
Treatment plan or consultation
3.0
21.7
177
915
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
6.9
21.5
35
56
XQ800
NOMESCO Finland
Prick test
4.5
20.8
56
142
J31.0
ICD-10 Finland
Chronic rhinitis
4.1
20.8
66
190
J01AA02
ATC
doxycycline; systemic
5.0
20.4
294
2085
H02AB04
ATC
methylprednisolone; systemic
3.7
20.4
76
245
XF400
NOMESCO Finland
ECG with 12 standard connections
3.7
20.3
79
262
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
20.1
129
578
Z31.5
ICD-10 Finland
Genetic counselling
4.6
19.8
51
125
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.0
19.7
135
626
R01AD05
ATC
budesonide; nasal
4.7
19.6
49
117
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.9
19.5
25
30
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
18.9
18
*
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
18.9
18
*
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
18.9
18
*
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
74.4
18.9
21
*
J05AB11
ATC
valaciclovir; oral
3.3
18.9
90
338
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.2
18.8
245
1585
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.8
18.7
46
108
WX882
NOMESCO Finland
High dependency care
7.4
18.5
28
41
R03AC13
ATC
formoterol; inhalant
5.9
18.5
35
65
Z3226
NOMESCO Finland
Physiotherapist
3.2
18.5
96
379
J02AC01
ATC
fluconazole; systemic
2.8
18.5
178
980
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
18.4
112
484
XG474
NOMESCO Finland
Exhalation nntrogen oxide
7.0
18.2
29
45
R06AE07
ATC
cetirizine; oral
2.8
18.1
195
1132
L04AX01
ATC
azathioprine; systemic
6.1
18.1
33
59
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.8
18.0
62
188
B99
ICPC
Blood/lymph/spleen disease other
70.7
17.9
20
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
17.9
17
*
J05AB01
ATC
aciclovir; systemic
2.9
17.9
112
491
N02AA05
ATC
oxycodone; systemic
3.5
17.7
74
255
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
25.8
17.6
24
10
JN3AD
NOMESCO Finland
Abdominal CT examination
3.6
17.5
67
218
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
23.4
17.1
24
11
Z2221
NOMESCO Finland
Medical doctor
2.8
17.0
130
630
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.9
16.9
27
42
R03AC12
ATC
salmeterol; inhalant
6.0
16.8
31
56
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
95.0
16.7
18
*
N03AX16
ATC
[U] pregabalin
2.9
16.6
103
446
ZX108
NOMESCO Finland
Inhalation
42.5
16.5
20
5
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
16.5
161
879
ZXA05
NOMESCO Finland
Left side
2.9
16.4
99
422
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.2
16.4
48
129
H04.10
ICD-10 Finland
Dry eye syndrome
3.3
16.2
72
257
A01AB09
ATC
miconazole; local oral
4.2
16.1
47
126
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
5.9
16.0
30
55
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
16.0
52
151
B28
ICPC
Limited function/disability (B)
35.3
15.9
20
6
R4110
NOMESCO Finland
Physiotherapy
2.7
15.9
125
611
J01DA06
ATC
[U] cefuroxime
3.1
15.9
79
302
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.2
15.8
34
71
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.8
15.8
101
444
A07AA09
ATC
vancomycin; oral
23.5
15.8
22
10
ZX110
NOMESCO Finland
Intracutaneous
89.5
15.7
17
*
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
40.2
15.6
19
5
UJF92
NOMESCO Finland
Capsular endoscopy
7.4
15.5
23
33
R03BA01
ATC
beclometasone; inhalant
3.3
15.4
69
247
R01AD58
ATC
fluticasone, combinations; nasal
2.6
15.4
130
656
N02AX02
ATC
tramadol; systemic, rectal
2.5
15.4
167
950
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
12.7
15.4
27
23
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.6
15.2
38
90
ZYC01
NOMESCO Finland
Remote contact by phone
4.1
15.2
45
122
R03AK07
ATC
formoterol and budesonide; inhalant
2.8
15.2
102
459
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.6
15.0
38
91
ZXE00
NOMESCO Finland
One hour or less
2.5
15.0
161
909
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
14.9
145
780
SPAT1255
SPAT
Intravenous administration of medicine
4.7
14.9
36
83
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.0
14.9
77
300
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
26.5
14.9
20
8
R06.0
ICD-10 Finland
Dyspnoea
2.7
14.8
110
520
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.4
14.7
39
97
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
+∞
14.7
14
*
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
14.7
14
*
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
7.0
14.7
23
35
XA800
NOMESCO Finland
Neuropsychological investigation
4.4
14.5
39
98
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
28.7
14.4
19
7
R03BA05
ATC
fluticasone; inhalant
2.8
14.2
94
418
ZXA00
NOMESCO Finland
Right side
2.7
14.0
102
475
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
14.0
65
237
R03AC03
ATC
terbutaline; inhalant
3.1
14.0
68
255
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.5
13.9
52
166
R01AD12
ATC
fluticasone furoate; nasal
2.4
13.7
149
836
ZX121
NOMESCO Finland
Central venous catheter
35.7
13.6
17
5
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
13.6
13
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.4
13.6
23
38
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
27.1
13.5
18
7
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
22.3
13.5
19
9
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.9
13.4
78
323
A07EA06
ATC
budesonide; oral, local oral
4.9
13.4
31
69
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
41.9
13.3
16
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
13.2
63
233
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
13.2
57
199
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.6
13.0
98
462
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
52.2
12.9
15
*
R01BA52
ATC
pseudoephedrine, combinations; oral
2.4
12.9
125
663
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.6
12.8
92
424
M04AA01
ATC
allopurinol; systemic
3.6
12.7
45
138
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
72.8
12.7
14
*
A02BC01
ATC
omeprazole; systemic
2.5
12.5
104
513
J01DA01
ATC
[U] cefalexin
2.4
12.5
226
1562
WX892
NOMESCO Finland
Monitored bed care
3.8
12.4
40
115
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
22.3
12.1
17
8
M05BX04
ATC
denosumab; parenteral
5.0
12.1
27
58
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
14.1
12.1
20
15
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.9
12.0
66
264
ZY010
NOMESCO Finland
Hospital outpatient
3.8
12.0
38
108
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
12.0
41
123
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
10.2
11.9
23
24
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.0
11.9
58
217
R1250
NOMESCO Finland
Evaluation of functional capability
5.8
11.8
22
40
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.5
11.8
30
72
Z2446
NOMESCO Finland
Social worker
3.4
11.8
45
145
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
3.3
11.7
47
156
ZXD05
NOMESCO Finland
Urgent procedure
2.3
11.7
124
678
L01BA01
ATC
methotrexate; systemic
6.0
11.6
21
37
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
4.4
11.6
30
73
A02BC03
ATC
lansoprazole; oral
2.4
11.5
108
561
WX002
NOMESCO Finland
Sedation and analgesia
2.7
11.4
76
335
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
15.8
11.4
18
12
ZX114
NOMESCO Finland
Intramuscular
10.2
11.4
22
23
J20
ICD-10 Finland
Acute bronchitis
3.0
11.4
56
210
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.2
11.4
24
49
B03BA03
ATC
hydroxocobalamin; parenteral
5.2
11.4
24
49
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.8
11.4
36
102
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
36.4
11.4
14
*
1XC02, ,
NOMESCO Finland
36.4
11.4
14
*
A06AD11
ATC
lactulose; oral
3.2
11.3
50
176
R03AK03
ATC
[U] fenoterol and ipratropium bromide
5.8
11.3
21
38
A28
ICPC
Limited function/disability NOS
3.0
11.3
56
211
J01
ICD-10 Finland
Acute sinusitis
3.7
11.2
38
113
J01DB01
ATC
cefalexin; oral
3.5
11.2
297
2398
R4190
NOMESCO Finland
Nutritional therapy
4.2
11.1
31
80
J15.8
ICD-10 Finland
Other bacterial pneumonia
44.9
11.0
13
*
S01GX01
ATC
cromoglicic acid; ophthalmic
2.4
11.0
96
481
L04AA06
ATC
mycophenolic acid; systemic
9.3
10.9
22
25
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.5
10.7
21
40
E0000UV, ,
ATC
2.2
10.7
166
1052
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
10.7
66
280
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
5.1
10.7
23
48
D07AB08
ATC
desonide; topical
2.9
10.6
55
212
R03BC03
ATC
nedocromil; inhalant
3.7
10.6
36
107
D70.89
ICD-10 Finland
Neutropenic splenomegaly
14.9
10.6
17
12
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
10.5
10
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.0
10.4
49
179
J01DC02
ATC
cefuroxime; systemic
3.9
10.4
32
89
A02BC02
ATC
pantoprazole; systemic
2.3
10.4
233
1700
N06AX21
ATC
duloxetine; oral
2.7
10.3
62
259
P01AB01
ATC
metronidazole; oral, rectal
2.1
10.3
157
984
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
10.2
50
187
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
10.2
76
353
R81
ICPC
Pneumonia
4.9
10.2
23
50
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.1
10.2
22
46
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
10.0
137
821
A46
ICD-10 Finland
Erysipelas
2.8
10.0
56
225
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.4
10.0
39
127
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
10.0
64
276
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
12.7
10.0
17
14
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
9.9
144
882
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.8
9.9
23
51
C10AC01
ATC
colestyramine; oral
5.1
9.9
21
43
H65.3
ICD-10 Finland
Chronic mucoid otitis media
4.9
9.9
22
47
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
11.1
9.9
18
17
J96.0
ICD-10 Finland
Acute respiratory failure
20.8
9.9
14
7
Z71.8
ICD-10 Finland
Other specified counselling
2.1
9.9
142
867
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
13.9
9.8
16
12
R03AK11
ATC
formoterol and fluticasone; inhalant
7.5
9.7
22
31
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
5.0
9.7
21
44
B01AB05
ATC
enoxaparin; parenteral
2.2
9.6
105
574
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.4
9.6
25
61
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
9.6
44
158
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
9.6
91
469
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.2
9.6
99
529
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.8
9.5
52
206
C03DA01
ATC
spironolactone; oral
3.1
9.5
42
148
J01.4
ICD-10 Finland
Acute pansinusitis
12.9
9.5
16
13
R06AE09
ATC
levocetirizine; oral
2.5
9.5
67
303
B34.9
ICD-10 Finland
Viral infection, unspecified
4.7
9.5
22
49
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
22.5
9.4
13
6
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
9.4
9
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
9.4
9
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
9.4
9
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
9.4
38
127
R01AD11
ATC
triamcinolone; nasal
3.0
9.3
45
167
ZX100
NOMESCO Finland
Oral
14.2
9.3
15
11
J01CF05
ATC
flucloxacillin; systemic
3.1
9.2
40
139
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.0
9.2
20
42
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
5.0
9.2
20
42
JN6AD
NOMESCO Finland
CT of torso and neck
9.5
9.1
18
20
PJA10
NOMESCO Finland
Exploration of lymph nodes
10.5
9.1
17
17
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
9.1
46
175
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
7.8
9.1
20
27
R06AX27
ATC
desloratadine; oral
2.1
9.0
129
780
N02BF02
ATC
pregabalin; oral
3.3
9.0
36
119
N03AX11
ATC
topiramate; oral
4.6
9.0
22
51
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
24.8
9.0
12
5
R01AD01
ATC
beclometasone; nasal
2.4
9.0
69
324
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.9
8.9
20
43
A02BC05
ATC
esomeprazole; systemic
2.0
8.8
146
930
Z50.1
ICD-10 Finland
Other physical therapy
3.9
8.8
26
70
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.1
8.8
38
132
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
51.4
8.7
10
*
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
51.4
8.7
10
*
J01DA08
ATC
[U] cefaclor
2.7
8.7
52
216
P01BA02
ATC
hydroxychloroquine; oral
2.9
8.6
43
162
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.5
8.6
59
262
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.8
8.6
27
76
N05BA01
ATC
diazepam; systemic, rectal
2.6
8.6
56
243
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.3
8.6
34
112
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
28.4
8.5
11
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.0
8.5
20
30
UDM02
NOMESCO Finland
Sinoscopy
7.0
8.5
20
30
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.2
8.5
23
58
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.4
8.5
32
102
H65.2
ICD-10 Finland
Chronic serous otitis media
8.2
8.5
18
23
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
92.3
8.5
9
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.9
8.4
17
20
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
11.2
8.4
15
14
A41.8
ICD-10 Finland
Other specified sepsis
9.8
8.4
16
17
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
8.4
92
501
D73.1
ICD-10 Finland
Hypersplenism
+∞
8.4
8
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
8.4
8
*
2790B
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI A]
+∞
8.4
8
*
27510
ICD-8 Finland
Plasma protein abnormalities, Hypogammaglobulinaemia
+∞
8.4
8
*
2790C
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]
+∞
8.4
8
*
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
8.4
8
*
WX704
NOMESCO Finland
Intubation
3.0
8.3
39
142
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.7
8.3
48
196
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
15.0
8.3
13
9
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
8.2
53
228
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.1
8.2
103
589
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.0
8.2
121
735
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.2
8.2
34
115
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.6
8.2
50
210
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
17.7
8.1
12
7
WX872
NOMESCO Finland
Intensive care
4.0
8.1
23
60
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.6
8.1
18
25
B03XA01
ATC
erythropoietin; parenteral
22.7
8.1
11
5
J01CA04
ATC
amoxicillin; systemic
2.7
8.1
291
2435
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.4
8.0
20
33
RD210, ,
NOMESCO Finland
6.4
8.0
20
33
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.4
8.0
20
33
N03AX12
ATC
[U] gabapentin; oral
2.3
8.0
66
319
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.8
8.0
18
39
A04AA02
ATC
granisetron; systemic, transdermal
3.3
7.9
30
96
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
7.9
42
164
M05BA07
ATC
risedronic acid; oral
9.8
7.9
15
16
D07AC01
ATC
betamethasone; topical
2.0
7.9
130
820
A03
ICPC
Fever
2.1
7.8
84
453
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
46.1
7.7
9
*
K11.2
ICD-10 Finland
Sialoadenitis
4.7
7.7
18
40
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.5
7.7
54
242
127
Kela drug reimbursment
Transplant complication
8.3
7.7
16
20
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.3
7.7
20
49
M13.9
ICD-10 Finland
Arthritis, unspecified
3.0
7.6
35
126
J45
ICD-10 Finland
Asthma
2.6
7.6
46
192
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.4
7.6
28
88
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.4
7.6
17
24
N03AE01
ATC
clonazepam; systemic
3.5
7.6
27
83
I50.9
ICD-10 Finland
Heart failure, unspecified
3.3
7.5
29
94
A05AA02
ATC
ursodeoxycholic acid; oral
7.9
7.5
16
21
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.9
7.5
16
21
R04.0
ICD-10 Finland
Epistaxis
3.2
7.5
31
105
R75
ICPC
Sinusitis acute/chronic
3.2
7.5
31
105
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
81.9
7.4
8
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
13.8
7.4
12
9
XX3DW
NOMESCO Finland
Time consuming IT work
2.6
7.4
46
194
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.7
7.4
15
18
ZXD20
NOMESCO Finland
Day surgery
2.4
7.4
54
247
J01.1
ICD-10 Finland
Acute frontal sinusitis
6.0
7.3
19
33
C08DA01
ATC
verapamil; systemic
3.9
7.3
22
60
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
7.3
7
*
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
7.3
7
*
D84.1
ICD-10 Finland
Defects in the complement system
+∞
7.3
7
*
D81.1
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
+∞
7.3
7
*
2790A
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[AGAMMAGLOBULINAEMIA (BRUTON)]
+∞
7.3
7
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
7.3
35
129
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
7.3
156
1065
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
16.2
7.3
11
7
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
16.2
7.3
11
7
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
16.2
7.3
11
7
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
16.2
7.3
11
7
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
16.2
7.3
11
7
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.6
7.3
24
70
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.7
7.3
17
38
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.7
7.3
17
38
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
7.3
111
678
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
8.2
7.2
15
19
GD1BG
NOMESCO Finland
MRI of lungs and pleura with high intensity magnet
30.7
7.2
9
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.2
7.2
19
47
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
20.6
7.2
10
5
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.7
7.1
23
66
L28
ICPC
Limited function/disability (L)
2.4
7.1
56
264
S01AA01
ATC
chloramphenicol; ophthalmic
3.6
7.1
24
71
UDC00
NOMESCO Finland
Ear microscopy
2.9
7.1
34
125
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.0
7.1
20
52
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.7
7.0
22
62
L04AX03
ATC
methotrexate; systemic
2.6
7.0
44
187
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.6
7.0
23
67
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
8.5
6.9
14
17
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
5.9
6.9
18
32
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
11.3
6.8
12
11
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
11.3
6.8
12
11
FM2CE, ,
NOMESCO Finland
9.6
6.8
13
14
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
4.4
6.8
17
40
WX720
NOMESCO Finland
Own respiration
3.6
6.8
23
68
R4120
NOMESCO Finland
Occupational therapy
2.8
6.8
35
134
N05CD07
ATC
temazepam; oral
2.8
6.8
35
134
N05CF01
ATC
zopiclone; oral
1.9
6.8
107
658
M35.7
ICD-10 Finland
Hypermobility syndrome
7.4
6.8
15
21
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.9
6.7
20
54
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.3
6.7
16
516
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.7
6.7
36
141
B07.9
ICD-10 Finland
Verruca simplex
3.7
6.7
21
59
A01AB04
ATC
amphotericin B; local oral
4.0
6.6
19
50
I50.0
ICD-10 Finland
Congestive heart failure
4.3
6.6
17
41
4224
FHL
Endonasal anthrostomy
12.6
6.6
11
9
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
12.6
6.6
11
9
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
6.6
36
142
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.9
6.6
31
113
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.9
6.6
31
113
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
6.6
154
1072
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
5.9
6.5
17
30
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.7
6.5
36
143
XF404
NOMESCO Finland
Ambulatory ECG
2.8
6.5
32
120
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
71.2
6.4
7
*
K90.8
ICD-10 Finland
Other intestinal malabsorption
71.2
6.4
7
*
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
14.7
6.4
10
7
GX1K5
NOMESCO Finland
Diffusion capacity
14.7
6.4
10
7
Z2445
NOMESCO Finland
Psychologist
3.0
6.4
28
98
R49.01
ICD-10 Finland
Functional dysphonia
4.0
6.3
18
47
K90.0
ICD-10 Finland
Coeliac disease
4.0
6.3
18
47
DPA30
NOMESCO Finland
Sphenotomy
11.3
6.3
11
10
XG405
NOMESCO Finland
Education on PEF monitoring
11.3
6.3
11
10
N06AX17
ATC
milnacipran; oral
11.3
6.3
11
10
R06AX22
ATC
ebastine; oral
2.1
6.3
73
401
A02BA02
ATC
ranitidine; systemic
2.2
6.3
59
299
J05AH02
ATC
oseltamivir; oral
18.4
6.3
9
5
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.3
6.3
14
20
SBA00
NOMESCO Finland
Microbiological examinations
5.2
6.3
18
36
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.4
6.3
23
72
4AA24, ,
NOMESCO Finland
+∞
6.3
6
*
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
6.3
6
*
ZX131
NOMESCO Finland
Intrathecal
+∞
6.3
6
*
D81.8
ICD-10 Finland
Other combined immunodeficiencies
+∞
6.3
6
*
JK3MN
NOMESCO Finland
Bile absorbtion isotope examination
+∞
6.3
6
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
6.3
6
*
3XA02, ,
NOMESCO Finland
+∞
6.3
6
*
D81.9
ICD-10 Finland
Combined immunodeficiency, unspecified
+∞
6.3
6
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
6.3
6
*
D06AX01
ATC
fusidic acid; topical
2.5
6.3
42
184
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
27.2
6.3
8
*
DMB10
NOMESCO Finland
Radical maxillary antrotomy
27.2
6.3
8
*
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
27.2
6.3
8
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
27.2
6.3
8
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.5
6.2
15
24
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.4
6.2
43
191
R11
ICD-10 Finland
Nausea and vomiting
2.5
6.2
40
172
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.8
6.2
31
117
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
6.1
77
436
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.6
6.1
36
148
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.6
6.1
20
58
C08CA05
ATC
nifedipine; systemic
3.5
6.1
21
63
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
8.8
6.1
12
14
J30.0
ICD-10 Finland
Vasomotor rhinitis
5.4
6.1
17
33
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
6.1
45
206
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
10.3
6.1
11
11
M03BX01
ATC
baclofen; systemic
5.7
6.1
16
29
R04.2
ICD-10 Finland
Haemoptysis
5.7
6.1
16
29
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
6.2
6.1
15
25
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
6.2
6.1
15
25
N02AC04
ATC
dextropropoxyphene; oral
6.2
6.1
15
25
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
6.1
28
101
SAA04
NOMESCO Finland
Special examination of mouth
2.9
6.1
28
101
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
6.0
42
187
WX402
NOMESCO Finland
General anaesthesia
1.9
6.0
86
509
R13
ICD-10 Finland
Dysphagia
2.8
6.0
30
113
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
165
16
206.50
307.65
3.6
1.3
—
—
—
0
0
173
30
120.91
307.65
3.6
1.3
1195.06
1567.74
e6/l
1.19
150
23
271
201
72.83
307.65
6.4
1.5
0.92
1.47
g/l
1.78
236
191
122
24
80.35
221.29
3.7
1.3
513.46
789.69
e6/l
0.88
95
16
121
26
73.16
215.47
4.0
1.3
191.28
231.47
e6/l
0.56
98
19
106
27
57.53
180.53
2.2
1.4
0.25
0.38
g/l
1.42
79
18
106
27
57.53
180.53
2.2
1.4
1.81
3.33
g/l
2.00
79
17
106
27
57.53
180.53
2.2
1.4
4.43
7.00
g/l
3.57
80
18
112
51
32.83
159.33
2.2
1.4
0.19
0.67
g/l
3.82
78
42
180
240
15.41
142.90
2.3
1.3
73.43
326.01
u/ml
1.42
119
225
275
752
17.44
118.81
6.5
1.4
1.19
2.31
g/l
15.79
192
480
113
5
342.81
118.35
3.2
1.2
13.92
11.00
u/l
—
113
5
96
62
21.48
115.95
7.6
5.3
572.24
312.00
iu/ml
—
17
8
91
73
16.87
97.33
2.8
1.7
—
—
—
0
0
88
68
17.32
96.05
4.1
2.9
—
—
—
0
0
93
80
15.83
95.44
3.0
1.9
—
—
—
0
0
155
300
8.90
85.98
3.5
1.7
—
—
—
0
0
122
185
9.91
83.33
3.7
1.6
—
—
—
0
0
97
116
11.45
79.38
3.2
1.5
—
—
—
0
0
55
23
28.53
78.76
3.3
1.1
—
—
—
0
0
96
115
11.39
78.41
2.1
1.5
1.22
1.20
g/l
0.16
87
110
54
22
29.19
78.03
3.3
1.0
—
—
—
0
0
77
68
14.49
77.06
2.4
1.5
—
—
—
0
0
169
399
7.67
76.35
4.2
1.9
—
—
—
0
0
54
26
24.67
73.14
5.2
2.7
—
—
—
0
0
62
46
16.39
68.33
2.9
2.2
—
—
—
0
0
134
282
7.34
66.70
3.9
1.8
—
—
—
0
0
49
25
22.87
64.59
5.5
2.7
—
—
—
0
0
47
23
23.69
62.99
1.8
1.9
—
—
—
0
0
73
80
11.45
62.89
1.9
1.2
—
—
—
0
0
62
56
13.42
60.66
2.3
1.6
—
—
—
0
0
313
1581
22.42
58.81
32.3
6.5
1.69
2.05
e9/l
2.62
313
1403
313
1594
22.07
57.88
33.7
7.0
0.16
0.19
e9/l
2.51
313
1405
50
0
+∞
53.63
2.0
0.0
0.75
—
mg/l
—
33
0
50
0
+∞
53.63
2.0
0.0
1.03
—
mg/l
—
30
0
50
0
+∞
53.63
2.0
0.0
0.70
—
mg/l
—
28
0
50
0
+∞
53.63
2.0
0.0
1.60
—
mg/l
—
25
0
50
0
+∞
53.63
2.0
0.0
0.89
—
mg/l
—
30
0
50
0
+∞
53.63
2.0
0.0
0.78
—
mg/l
—
33
0
50
0
+∞
53.63
2.0
0.0
0.73
—
mg/l
—
26
0
50
0
+∞
53.63
2.0
0.0
2.88
—
mg/l
—
29
0
50
0
+∞
53.63
2.0
0.0
0.37
—
mg/l
—
31
0
50
0
+∞
53.63
2.0
0.0
2.32
—
mg/l
—
29
0
48
35
15.89
53.01
2.6
1.7
—
—
—
0
0
47
35
15.51
51.27
2.6
1.7
—
—
—
0
0
147
420
5.53
50.85
3.6
2.5
2.46
2.35
g/l
1.45
147
390
313
1701
19.37
50.73
39.8
10.2
3.68
3.90
e9/l
1.03
313
1480
150
450
5.30
48.63
3.9
2.5
12.78
13.88
umol/l
0.78
150
420
54
55
11.56
48.50
2.6
1.6
—
—
—
0
0
63
85
8.94
45.79
3.3
1.3
—
—
—
0
0
36
20
20.10
45.32
1.1
7.8
—
42.17
u/ml
—
0
6
42
0
+∞
44.83
1.8
0.0
0.36
—
iu/ml
—
24
0
47
50
10.80
40.76
2.2
1.5
—
—
—
0
0
112
308
5.00
39.28
3.5
2.0
345.58
371.09
nmol/l
0.56
106
294
42
40
11.90
39.23
2.7
1.6
—
—
—
0
0
34
23
16.38
38.78
2.6
2.1
—
—
—
0
0
34
23
16.38
38.78
2.6
2.1
—
—
—
0
0
34
23
16.38
38.78
2.6
2.1
—
—
—
0
0
54
78
8.09
36.79
4.1
1.8
1.20
0.89
ug/l
0.26
49
72
50
67
8.63
36.26
2.2
1.6
—
—
—
0
0
250
1318
4.77
35.10
21.9
7.5
1.21
1.21
mmol/l
0.16
228
1146
39
6
73.41
34.85
1.1
1.0
97.28
92.00
%
—
39
6
35
32
12.12
33.44
4.9
1.5
—
—
—
0
0
34
30
12.53
33.21
2.1
1.1
0.98
0.25
u/ml
0.60
23
14
36
35
11.43
33.03
4.8
1.4
—
—
—
0
0
36
35
11.43
33.03
4.8
1.4
—
—
—
0
0
36
35
11.43
33.03
4.8
1.4
—
—
—
0
0
35
33
11.75
32.76
4.9
1.5
—
—
—
0
0
35
33
11.75
32.76
4.9
1.5
—
—
—
0
0
57
99
6.76
32.71
1.9
2.3
1.36
1.43
g/l
0.17
47
89
221
1102
4.08
32.68
7.2
3.1
31.77
31.31
u/l
0.11
216
1048
130
453
4.10
32.64
2.6
2.7
211.72
107.82
ug/g
1.54
115
370
43
55
8.85
32.28
1.9
1.9
122.00
132.81
g/l
—
10
43
44
59
8.46
31.78
2.0
1.9
—
—
—
0
0
35
36
10.76
30.86
1.4
1.4
—
—
—
0
0
245
1350
4.22
30.40
39.3
10.5
0.00
0.00
e9/l
0.24
235
1080
67
150
5.36
29.34
2.1
2.1
3.17
4.35
iu/ml
0.42
19
32
314
2131
12.09
28.90
30.6
8.0
90.08
78.19
u/l
5.84
314
2027
34
37
10.14
28.77
1.7
1.2
—
—
—
0
0
46
79
6.61
26.51
1.6
1.3
2.31
0.90
u/ml
—
9
6
42
68
6.94
25.57
1.9
1.4
80.77
145.18
au/ml
2.17
13
19
46
84
6.21
24.91
2.6
2.7
0.56
0.90
g/l
0.29
41
78
53
113
5.40
24.34
2.2
1.4
—
—
—
0
0
34
46
8.13
24.22
1.7
1.3
—
—
—
0
0
34
46
8.13
24.22
1.7
1.3
—
—
—
0
0
42
74
6.36
23.53
2.6
3.0
3.83
1.34
index
0.75
12
44
30
10
32.84
23.22
1.5
1.4
—
—
—
0
0
56
131
4.95
23.07
1.7
1.2
0.52
3.10
u/ml
—
8
9
35
54
7.14
22.21
1.9
1.5
—
—
—
0
0
103
387
3.42
21.93
4.5
2.2
30.19
29.50
s
0.52
95
380
43
84
5.74
21.64
1.5
1.4
388.32
295.27
ug/g
2.11
34
53
155
748
3.03
21.44
5.9
3.0
0.26
0.38
e6/l
0.45
129
532
253
1608
3.51
21.33
17.7
5.2
6.38
6.52
mmol/l
0.53
247
1514
95
359
3.32
19.83
2.0
1.6
1435.27
1136.99
nmol/l
2.17
84
268
44
101
4.88
18.41
1.7
1.4
1.66
5.76
u/ml
—
9
25
44
101
4.88
18.41
1.7
1.3
2.90
2.99
u/ml
—
7
14
75
259
3.46
17.94
19.0
4.3
2.06
1.82
mmol/l
0.25
69
217
72
243
3.52
17.84
27.3
11.5
0.43
0.98
mmol/l
0.43
57
203
73
249
3.48
17.79
26.8
11.2
5.01
5.16
kpa
0.57
67
238
73
249
3.48
17.79
26.8
11.2
11.96
12.63
kpa
0.49
66
239
28
43
7.03
17.77
1.6
1.1
—
—
—
0
0
237
1536
2.96
17.57
6.4
3.5
0.00
0.00
estimate
0.50
61
313
133
648
2.77
17.28
5.4
2.8
1472.73
643.63
ng/l
0.77
122
528
23
9
27.33
17.15
1.5
1.1
—
—
—
0
0
237
1550
2.91
17.01
6.4
3.5
21.05
9.53
estimate
0.22
63
318
136
677
2.72
16.86
3.2
1.8
1.08
1.13
mg/l
0.09
118
513
25
14
19.20
16.74
2.6
2.2
—
—
—
0
0
25
14
19.20
16.74
2.6
2.2
—
—
—
0
0
25
14
19.20
16.74
2.6
2.2
—
—
—
0
0
25
14
19.20
16.74
2.6
2.2
—
—
—
0
0
23
10
24.61
16.67
1.5
1.1
—
—
—
0
0
237
1561
2.87
16.57
6.4
3.6
0.05
0.02
estimate
0.24
62
301
24
34
7.54
16.32
1.3
1.1
—
—
—
0
0
27
20
14.60
16.30
1.7
1.1
—
—
—
0
0
36
78
5.06
16.06
1.8
1.3
23.69
66.00
u/ml
—
11
9
28
24
12.64
15.88
4.7
3.1
—
—
—
0
0
19
5
40.18
15.55
6.3
6.4
—
—
—
0
0
32
65
5.35
15.33
3.6
1.5
4.84
19.81
e6/l
0.60
25
42
149
809
2.54
15.09
5.0
2.1
150.61
256.91
u/l
0.62
142
777
21
10
22.32
14.85
2.9
2.6
—
—
—
0
0
21
10
22.32
14.85
2.9
2.6
—
—
—
0
0
21
10
22.32
14.85
2.9
2.6
—
—
—
0
0
32
67
5.18
14.82
3.6
1.6
8.88
172.28
e6/l
0.84
26
46
44
122
4.01
14.39
27.1
10.7
25.15
24.90
mmol/l
0.17
39
114
81
332
2.91
14.25
21.8
8.0
104.44
104.32
mmol/l
0.09
81
332
33
74
4.85
14.12
2.1
1.3
168.93
218.97
u/ml
0.50
27
40
35
83
4.60
14.00
6.3
1.9
—
—
—
0
0
31
68
4.93
13.60
9.2
4.4
17.35
29.33
mg/l
1.38
24
60
31
68
4.93
13.60
9.1
4.4
23.02
125.05
mg/l
0.66
23
61
47
143
3.67
13.45
2.5
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
62
5.03
13.10
11.0
3.3
0.38
0.36
iu/ml
0.10
24
26
39
106
4.04
13.08
1.6
1.2
—
—
—
0
0
63
235
3.08
13.03
5.0
3.1
—
—
—
0
0
129
696
2.41
12.79
7.4
2.8
316.34
326.92
umol/l
0.52
123
626
50
166
3.37
12.51
8.2
3.5
1.07
1.48
mmol/l
0.29
39
116
46
145
3.53
12.47
6.0
2.5
206.90
111.70
ng/l
0.44
41
130
104
515
2.49
12.39
2.2
1.7
490.06
14856315.80
pmol/l
0.50
98
451
144
827
2.32
12.26
7.3
3.6
0.00
0.01
estimate
0.80
61
298
18
10
18.96
12.19
1.2
2.2
—
—
iu/ml
—
0
0
22
21
11.14
11.95
1.2
1.1
—
—
—
0
0
35
95
4.00
11.74
1.5
1.5
0.01
0.01
iu/ml
—
7
14
27
60
4.81
11.65
7.3
4.2
2.74
2.80
ratio
0.02
19
32
21
20
11.13
11.44
2.2
1.2
—
—
—
0
0
22
23
10.17
11.43
1.2
1.1
—
—
—
0
0
78
349
2.62
11.39
5.5
2.8
8.36
6.24
umol/l
0.41
70
313
21
21
10.60
11.17
3.0
1.7
—
—
—
0
0
50
179
3.12
11.02
25.1
4.2
25.09
24.30
mmol/l
1.25
50
179
49
179
3.04
10.42
6.5
4.3
1.21
1.23
mmol/l
1.37
49
159
173
1124
2.14
10.35
2.9
2.0
90.68
97.72
pmol/l
1.47
117
572
21
42
5.27
10.19
2.0
1.4
23.05
24.20
ng/l
0.10
21
42
31
87
3.83
9.92
4.4
2.1
—
—
—
0
0
51
197
2.88
9.80
8.7
3.5
4.96
5.11
kpa
1.05
46
191
13
6
22.47
9.42
1.8
1.8
—
—
—
0
0
21
29
7.66
9.37
2.2
1.1
—
—
—
0
0
84
424
2.32
9.29
4.4
2.9
3.43
3.07
e6/l
0.14
41
191
188
1296
2.06
9.22
5.7
2.7
—
—
estimate
—
0
0
20
27
7.81
9.07
1.2
1.6
—
—
—
0
0
96
517
2.21
9.06
6.1
3.2
141.50
265.40
ng/l
0.73
66
344
320
2879
5.57
8.89
61.6
14.7
139.45
139.74
mmol/l
1.47
320
2831
16
15
11.15
8.89
3.3
1.8
—
—
—
0
0
14
10
14.55
8.77
1.2
1.0
—
—
—
0
0
320
2888
5.43
8.74
62.0
14.8
3.91
3.95
mmol/l
1.75
320
2832
18
22
8.59
8.69
3.7
1.6
4.09
4.47
mg/l
0.11
18
22
15
13
12.03
8.66
1.4
1.2
—
—
—
0
0
16
16
10.45
8.62
3.3
1.8
—
—
—
0
0
18
37
5.09
8.46
1.8
1.3
—
—
—
0
0
19
27
7.40
8.38
1.6
1.1
—
—
—
0
0
13
9
14.97
8.27
1.3
1.7
—
—
—
0
0
16
18
9.28
8.13
1.5
1.2
0.54
0.51
ratio
—
10
10
11
5
22.68
8.06
1.3
1.6
—
—
—
0
0
11
5
22.68
8.06
1.3
1.4
—
—
—
0
0
15
16
9.76
7.86
1.2
1.1
1397.07
1816.31
miu/ml
0.48
15
16
15
16
9.76
7.86
3.5
1.8
—
—
—
0
0
145
949
1.95
7.86
6.0
3.2
94.14
103.21
ng/l
0.03
95
553
170
1177
1.92
7.75
6.4
3.3
0.00
0.03
estimate
1.15
56
262
11
6
18.90
7.65
1.4
1.2
—
—
—
0
0
11
6
18.90
7.65
1.4
1.3
—
—
—
0
0
13
11
12.25
7.64
3.5
1.9
94.92
61.94
ug/l
0.65
13
11
14
14
10.39
7.60
1.7
2.5
—
—
—
0
0
14
14
10.39
7.60
1.7
2.5
—
—
—
0
0
45
187
2.63
7.49
3.7
3.6
4.11
4.57
pmol/l
3.07
40
167
17
25
7.11
7.39
3.5
1.3
32.18
32.44
pg
0.07
17
25
83
456
2.10
7.28
4.0
2.8
1.00
0.79
e6/l
0.25
41
220
33
120
2.95
7.04
2.2
1.8
12.44
8.47
u/l
0.61
27
94
17
40
4.43
6.83
1.2
1.3
—
—
—
0
0
10
6
17.14
6.78
1.3
1.7
—
—
—
0
0
14
18
8.07
6.68
1.4
1.1
0.96
1.16
u/l
—
5
10
6
0
+∞
6.27
1.3
0.0
—
—
—
0
0
17
33
5.37
6.10
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
11
10.30
6.08
1.4
1.3
—
—
—
0
0
16
29
5.74
6.07
1.1
1.1
—
—
—
0
0
94
576
1.89
5.92
1.5
1.3
2.25
9.00
u/ml
2.45
35
238
131
892
1.78
5.84
5.6
2.9
0.00
0.01
estimate
0.74
54
258
11
12
9.44
5.83
2.5
3.4
200.45
143.38
mg/mmol
0.10
11
12
11
12
9.44
5.83
1.7
1.1
41.82
13.22
u/l
1.74
11
12
16
31
5.37
5.78
1.0
1.1
—
—
—
0
0
293
2554
2.38
5.76
67.8
16.7
14.20
13.40
%
14.95
293
2533
99
623
1.84
5.71
1.6
1.3
22.56
34.00
iu/ml
0.70
25
201
46
219
2.28
5.70
2.6
2.5
64.15
72.74
ml/min/173m2
0.76
27
94
16
32
5.20
5.64
1.3
1.2
—
—
—
0
0
13
20
6.72
5.61
1.6
1.0
—
—
—
0
0
9
7
13.17
5.61
1.7
1.0
—
—
—
0
0
16
42
3.95
5.60
3.2
1.8
1.73
1.76
mmol/l
0.06
16
42
11
13
8.71
5.60
1.2
1.3
—
—
—
0
0
11
13
8.71
5.60
2.4
1.4
—
—
—
0
0
11
13
8.71
5.60
2.4
1.4
—
—
—
0
0
16
34
4.89
5.37
1.3
1.3
—
—
—
0
0
104
676
1.79
5.34
5.0
2.3
—
—
—
0
0
12
18
6.87
5.30
1.3
1.2
—
—
—
0
0
5
0
+∞
5.22
1.6
0.0
—
—
—
0
0
32
138
2.46
4.94
24.7
3.2
0.57
0.59
%
0.15
32
138
10
13
7.89
4.88
1.5
1.0
—
—
—
0
0
104
696
1.72
4.75
5.6
3.4
1.02
1.02
kg/l
0.21
68
463
54
294
2.00
4.75
3.0
2.5
33.34
27.76
u/l
0.50
47
245
11
18
6.28
4.64
5.7
4.5
170.09
901.28
mg
1.88
11
18
7
5
14.26
4.59
1.0
1.2
—
—
—
0
0
13
27
4.97
4.54
2.8
1.8
90.20
90.92
%
0.20
13
27
257
2194
1.79
4.53
5.1
3.5
—
—
—
0
0
34
157
2.30
4.52
1.1
1.4
289.17
259.56
miu/ml
0.15
15
75
18
60
3.12
4.47
2.4
1.5
44376.75
6894.33
e6/l
0.57
12
39
13
28
4.79
4.42
1.3
1.3
—
—
—
0
0
15
45
3.45
4.38
4.7
2.5
16.31
16.90
%
0.33
15
45
13
29
4.62
4.29
1.3
1.3
—
—
—
0
0
301
2722
2.29
4.26
43.0
12.7
90.32
88.31
ml/min/173m2
0.86
293
2495
11
21
5.38
4.18
1.2
1.0
—
—
—
0
0
13
30
4.47
4.17
1.3
1.3
—
—
—
0
0
13
30
4.47
4.17
1.3
1.3
—
—
—
0
0
10
18
5.69
4.00
1.4
2.1
9.52
10.78
umol/l
—
10
18
10
19
5.39
3.85
4.5
2.7
—
—
—
0
0
9
15
6.14
3.84
3.1
3.9
0.56
0.93
index
—
9
15
41
219
2.00
3.80
2.1
1.4
—
—
—
0
0
11
24
4.70
3.78
2.8
2.9
102.73
101.58
%
0.02
11
24
107
761
1.60
3.73
1.9
1.7
—
—
—
0
0
18
67
2.78
3.72
1.3
1.4
0.28
0.38
nmol/l
0.38
12
54
8
12
6.80
3.69
2.1
1.4
—
—
—
0
0
8
12
6.80
3.69
2.1
1.4
—
—
—
0
0
114
829
1.57
3.60
1.4
1.4
0.48
1.74
u/ml
3.37
21
231
9
17
5.41
3.53
4.7
3.3
1.78
1.53
%
—
9
17
15
52
2.97
3.51
1.5
1.3
224.77
13.79
u/l
0.59
15
44
42
233
1.92
3.50
3.2
4.1
6.00
9.91
ug/l
0.62
36
186
10
22
4.65
3.45
1.2
1.5
2.40
3.21
u/field
—
10
14
13
37
3.62
3.44
4.1
3.2
28.55
23.46
nmol/l
0.77
13
32
8
14
5.83
3.36
1.3
1.0
—
—
—
0
0
17
65
2.70
3.36
1.2
1.2
1.50
1.60
u/ml
—
8
20
16
60
2.75
3.27
1.8
1.2
—
—
—
0
0
72
483
1.63
3.14
2.8
2.7
2.44
2.43
mmol/l
0.15
66
427
11
30
3.76
3.11
1.0
1.0
—
—
—
0
0
6
8
7.61
3.06
1.0
1.5
—
—
—
0
0
25
121
2.15
3.01
1.8
1.5
—
—
—
0
0
5
5
10.13
2.99
1.2
1.6
—
—
—
0
0
320
3057
2.92
2.91
66.6
16.4
75.75
72.43
umol/l
0.70
320
3023
8
18
4.53
2.81
2.5
1.4
—
—
—
0
0
259
2317
1.56
2.74
6.0
4.5
14.90
14.50
pmol/l
2.00
250
2171
6
10
6.09
2.71
1.0
1.3
—
—
—
0
0
242
2141
1.50
2.63
6.6
3.4
53.61
41.82
u/l
2.82
237
2059
5
7
7.23
2.55
1.2
1.0
—
—
—
0
0
6
11
5.53
2.55
1.5
3.8
0.65
0.61
mmol/l
—
6
11
22
408
0.51
2.52
1.6
2.0
3.15
3.45
ratio
0.52
15
319
13
52
2.56
2.39
2.3
2.8
5.75
7.45
pmol/l
0.43
13
52
25
133
1.95
2.38
1.6
1.3
—
—
—
0
0
10
33
3.09
2.37
1.2
3.0
7.57
2.78
nmol/l
—
10
33
15
66
2.33
2.28
2.5
1.1
99.75
12.50
iu/ml
—
8
14
15
66
2.33
2.28
1.5
1.2
—
—
—
0
0
291
2712
1.65
2.18
7.0
5.4
1.90
1.81
mu/l
0.73
285
2561
16
309
0.49
2.08
1.5
1.8
3.69
3.49
mmol/l
0.27
11
222
5
10
5.06
2.08
2.4
1.5
—
—
—
0
0
318
3054
2.35
1.99
41.6
11.2
30.33
27.41
u/l
2.17
318
2987
14
66
2.17
1.84
1.1
1.2
2.50
3.24
u/ml
—
6
29
14
66
2.17
1.84
1.1
1.1
—
—
—
0
0
119
971
1.35
1.84
3.6
3.4
7.47
8.13
mmol/l
0.77
112
835
6
18
3.37
1.75
1.3
1.3
143.83
111.33
pmol/l
—
6
18
5
13
3.89
1.72
1.0
3.3
218.60
197.08
u/l
—
5
13
38
255
1.55
1.67
2.1
1.3
68.04
144.26
u/ml
1.09
18
97
26
159
1.69
1.65
2.3
2.3
10902.33
5850.95
u/l
—
9
64
5
15
3.37
1.53
2.2
2.9
534.00
642.29
ml
—
5
7
7
27
2.63
1.52
1.3
1.7
—
—
—
0
0
17
94
1.85
1.50
1.7
1.1
—
—
—
0
0
17
94
1.85
1.50
1.7
1.1
—
—
—
0
0
272
2863
0.71
1.50
4.8
4.8
4.60
4.76
mmol/l
1.73
263
2714
9
37
2.47
1.49
2.0
1.5
335.44
299.39
mu/l
—
9
31
37
258
1.49
1.39
3.4
2.2
—
—
—
0
0
5
18
2.80
1.29
1.4
1.1
—
—
—
0
0
276
2887
0.72
1.29
5.2
5.3
2.71
2.83
mmol/l
1.40
266
2730
256
2707
0.75
1.29
4.5
4.0
1.43
1.28
mmol/l
2.45
249
2541
27
180
1.54
1.25
2.3
1.6
0.16
0.30
mg/l
—
9
84
6
126
0.47
1.19
1.7
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
20
2.52
1.15
1.0
2.2
274.66
118.50
%
—
5
20
273
2852
0.74
1.14
4.6
4.7
1.42
1.47
mmol/l
1.25
262
2693
12
67
1.82
1.06
2.6
1.9
—
—
—
0
0
99
842
1.25
1.06
4.0
4.2
20.44
9.74
mg/mmol
0.38
62
521
7
37
1.91
0.94
1.0
1.2
1.79
1.35
nmol/l
—
7
32
15
94
1.62
0.92
2.3
2.2
2.54
3.03
iu/l
—
8
40
57
465
1.27
0.86
2.9
2.1
—
—
—
0
0
39
309
1.30
0.75
3.7
2.2
—
—
—
0
0
60
502
1.24
0.75
3.0
2.2
—
—
—
0
0
20
275
0.71
0.74
14.5
5.9
—
—
—
0
0
26
194
1.37
0.74
1.9
2.4
45.81
46.62
u/ml
0.02
26
187
5
29
1.74
0.64
1.8
3.8
74.24
53.32
u/ml
—
5
29
66
572
1.19
0.59
1.8
1.5
—
—
—
0
0
322
3189
1.53
0.43
87.2
21.2
39.53
40.90
%
6.75
322
3159
322
3189
1.53
0.43
82.9
20.7
4.46
4.56
e12/l
2.34
322
3136
322
3188
1.55
0.43
83.2
20.8
238.20
257.90
e9/l
3.72
322
3140
322
3187
1.57
0.43
82.6
20.7
89.61
90.40
fl
1.68
322
3159
0
18
0.00
0.40
0.0
1.2
—
11.06
—
0
18
51
451
1.15
0.38
1.6
1.9
1.68
1.40
%
0.91
42
410
22
182
1.22
0.34
1.6
1.3
—
—
—
0
0
322
3190
1.51
0.33
83.9
20.9
130.77
136.89
g/l
10.10
322
3161
14
110
1.28
0.32
1.7
1.7
13.39
8.69
u/ml
—
8
24
54
487
1.13
0.32
3.1
3.9
19.60
23.12
%
0.73
22
176
9
73
1.24
0.25
2.2
1.8
—
—
—
0
0
16
180
0.88
0.13
1.1
1.0
—
—
—
0
0
5
48
1.04
0.09
2.4
1.7
13.76
13.24
%
—
5
48
7
66
1.06
0.08
1.7
1.5
49.04
53.59
ug/l
—
7
66
40
383
1.05
0.07
3.0
2.8
0.73
0.69
ug/l
0.08
30
199
8
95
0.84
0.06
1.4
1.8
204.25
235.89
pmol/l
—
8
87
272
2733
0.97
0.04
5.6
4.5
5.75
5.79
mmol/l
0.20
265
2561
126
1273
0.98
0.03
1.9
2.0
1.46
1.39
mmol/l
0.51
118
1108
266
2652
1.02
0.01
6.4
5.7
37.60
38.31
mmol/mol
0.59
259
2532
11
112
0.98
0.00
1.6
1.5
—
—
—
0
0
13
132
0.98
0.00
1.2
1.1
1.56
1.54
g/l
0.14
13
132
14
138
1.02
0.00
1.1
1.2
0.92
0.91
g/l
0.08
14
138
14
142
0.99
0.00
1.5
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
1.19
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
0.04
—
0
6
0
5
0.00
-0.00
0.0
3.2
—
66.44
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
8.0
3.8
35.44
28.09
mg/l
—
5
40
9
90
1.00
-0.00
1.9
1.7
—
—
—
0
0
7
72
0.97
-0.00
2.7
2.2
0.77
0.84
nmol/l
—
7
61
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_KELA_IMMUDEF and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_KELA_IMMUDEF | 5.013 [3.21, 7.83] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.595 |
During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 416 females with D3_KELA_IMMUDEF died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have D3_KELA_IMMUDEF.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.44% | No data |
| 5 | 3.202% | No data |
| 10 | 7.618% | No data |
| 15 | 14.22% | No data |
| 20 | 23.763% | No data |
Relationships between endpoints
↥Index endpoint: D3_KELA_IMMUDEF – Kela reimbursement Agammaglobulinemia (D80-84)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data